Effects of immune checkpoint inhibitor-based combination therapies on the gut microbiota in advanced melanoma patients

J. Li; L. Xu; Z. Peng; H. Jiang; F. Chao; Y. Ding; J. M. Moll; D. Li; X. Wen; J. Wang; Q. Ding; L. Zhang; K. Kristiansen; S. Brix; X. Zhang

doi:10.1016/j.annonc.2022.07.967

Effects of immune checkpoint inhibitor-based combination therapies on the gut microbiota in advanced melanoma patients

J. Li^*
, L. Xu
, Z. Peng
, H. Jiang
, F. Chao
, Y. Ding
, J. M. Moll
, D. Li
, X. Wen
, J. Wang
, Q. Ding
, L. Zhang
, K. Kristiansen
, S. Brix
, X. Zhang

^*Corresponding author for this work

Sun Yat-sen University Cancer Center
BGI Group
University of Chinese Academy of Sciences
University of Copenhagen

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	841P
Journal	Annals of Oncology
Volume	33
Issue number	Supplement 7
Pages (from-to)	S934-S934
Number of pages	1
ISSN	0923-7534
DOIs	https://doi.org/10.1016/j.annonc.2022.07.967
Publication status	Published - 2022
Event	2022 ESMO Congress - Paris, France Duration: 9 Sept 2022 → 13 Sept 2022

Conference

Conference	2022 ESMO Congress
Country/Territory	France
City	Paris
Period	09/09/2022 → 13/09/2022

Access to Document

10.1016/j.annonc.2022.07.967

OpenUrl availability

Check availability in DTU Findit

Cite this

Li, J., Xu, L., Peng, Z., Jiang, H., Chao, F., Ding, Y., Moll, J. M., Li, D., Wen, X., Wang, J., Ding, Q., Zhang, L., Kristiansen, K., Brix, S., & Zhang, X. (2022). Effects of immune checkpoint inhibitor-based combination therapies on the gut microbiota in advanced melanoma patients. Annals of Oncology, 33(Supplement 7), S934-S934. Article 841P. https://doi.org/10.1016/j.annonc.2022.07.967

@article{95cda5585c4d41f38d04ed388517083b,

title = "Effects of immune checkpoint inhibitor-based combination therapies on the gut microbiota in advanced melanoma patients",

author = "J. Li and L. Xu and Z. Peng and H. Jiang and F. Chao and Y. Ding and Moll, \{J. M.\} and D. Li and X. Wen and J. Wang and Q. Ding and L. Zhang and K. Kristiansen and S. Brix and X. Zhang",

year = "2022",

doi = "10.1016/j.annonc.2022.07.967",

language = "English",

volume = "33",

pages = "S934--S934",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "Supplement 7",

note = "2022 ESMO Congress ; Conference date: 09-09-2022 Through 13-09-2022",

}

Li, J, Xu, L, Peng, Z, Jiang, H, Chao, F, Ding, Y, Moll, JM, Li, D, Wen, X, Wang, J, Ding, Q, Zhang, L, Kristiansen, K, Brix, S & Zhang, X 2022, 'Effects of immune checkpoint inhibitor-based combination therapies on the gut microbiota in advanced melanoma patients', Annals of Oncology, vol. 33, no. Supplement 7, 841P, pp. S934-S934. https://doi.org/10.1016/j.annonc.2022.07.967

TY - ABST

T1 - Effects of immune checkpoint inhibitor-based combination therapies on the gut microbiota in advanced melanoma patients

AU - Li, J.

AU - Xu, L.

AU - Peng, Z.

AU - Jiang, H.

AU - Chao, F.

AU - Ding, Y.

AU - Moll, J. M.

AU - Li, D.

AU - Wen, X.

AU - Wang, J.

AU - Ding, Q.

AU - Zhang, L.

AU - Kristiansen, K.

AU - Brix, S.

AU - Zhang, X.

PY - 2022

Y1 - 2022

U2 - 10.1016/j.annonc.2022.07.967

DO - 10.1016/j.annonc.2022.07.967

M3 - Conference abstract in journal

SN - 0923-7534

VL - 33

SP - S934-S934

JO - Annals of Oncology

JF - Annals of Oncology

IS - Supplement 7

M1 - 841P

T2 - 2022 ESMO Congress

Y2 - 9 September 2022 through 13 September 2022

ER -